Camden Asset Management LP decreased its stake in Huntington Bancshares Inc (HBANP) by 0.69% based on its latest 2017Q4 regulatory filing with the SEC. Camden Asset Management LP sold 395 shares as the company’s stock 0.00% . The hedge fund held 56,571 shares of the major banks company at the end of 2017Q4, valued at $80.14M, down from 56,966 at the end of the previous reported quarter. Camden Asset Management LP who had been investing in Huntington Bancshares Inc for a number of months, seems to be less bullish one the $17.26 billion market cap company. The stock decreased 2.63% or $35.58 during the last trading session, reaching $1316. About 1,293 shares traded. Huntington Bancshares Incorporated (NASDAQ:HBANP) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.
Neville Rodie & Shaw Inc increased its stake in Celgene Corp (CELG) by 29.82% based on its latest 2017Q4 regulatory filing with the SEC. Neville Rodie & Shaw Inc bought 21,012 shares as the company’s stock declined 19.30% with the market. The institutional investor held 91,480 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $9.55 million, up from 70,468 at the end of the previous reported quarter. Neville Rodie & Shaw Inc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $68.75 billion market cap company. The stock increased 0.95% or $0.86 during the last trading session, reaching $91.4. About 1.51M shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 17, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.
Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 1 Sell and 14 Hold. Therefore 56% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. On Friday, October 27 the stock rating was maintained by SunTrust with “Buy”. On Wednesday, January 20 the stock rating was initiated by Credit Suisse with “Outperform”. The rating was initiated by Jefferies on Wednesday, September 9 with “Buy”. The rating was maintained by Oppenheimer on Wednesday, June 14 with “Buy”. On Wednesday, April 4 the stock rating was maintained by RBC Capital Markets with “Buy”. The firm has “Buy” rating by BMO Capital Markets given on Thursday, October 5. Citigroup initiated the shares of CELG in report on Thursday, February 25 with “Buy” rating. The firm has “Equal-Weight” rating by Barclays Capital given on Friday, October 27. The rating was maintained by SunTrust with “Buy” on Thursday, January 25. The firm has “Buy” rating by Jefferies given on Friday, June 23.
Neville Rodie & Shaw Inc, which manages about $1.50B and $948.73M US Long portfolio, decreased its stake in Boeing Co (NYSE:BA) by 1,932 shares to 51,298 shares, valued at $15.13 million in 2017Q4, according to the filing. It also reduced its holding in Costco Wholesale Corp (NASDAQ:COST) by 3,452 shares in the quarter, leaving it with 24,873 shares, and cut its stake in Wells Fargo (NYSE:WFC).
Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It dropped, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Salem Counselors reported 0.05% of its portfolio in Celgene Corporation (NASDAQ:CELG). Essex Finance Service holds 0.76% or 30,547 shares in its portfolio. New York-based Tompkins Corporation has invested 0.41% in Celgene Corporation (NASDAQ:CELG). Wedgewood Partners has 962,318 shares for 4.06% of their portfolio. Artisan Ptnrs Partnership has 0.06% invested in Celgene Corporation (NASDAQ:CELG). Davenport Lc reported 600,499 shares. Schroder Inv Mgmt Group accumulated 246,773 shares. Logan Cap reported 99,129 shares. Etrade Mngmt Ltd Co invested in 0.09% or 25,424 shares. Boston Private Wealth Lc stated it has 266,980 shares. Commonwealth Financial Bank Of Aus invested in 0.03% or 31,884 shares. Lateef Investment Mgmt Ltd Partnership invested 2.29% of its portfolio in Celgene Corporation (NASDAQ:CELG). 54.61M are owned by Blackrock Incorporated. Moreover, Mastrapasqua Asset Inc has 1.35% invested in Celgene Corporation (NASDAQ:CELG). Cornerstone Capital Incorporated accumulated 2,800 shares.